Akanocure Pharmaceuticals, Inc.
WEST LAFAYETTE, IN · Founded 2014 · CIK 0001638067 · Biotech · Private
Small molecule therapeutics for inflammatory and metabolic diseases
akanocure.com →- Grants
- $2.4M
- 4 awards
- Sector median: 1
- Raised
- $1.0M
- 1 Form D · Mar 2015
- 139 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 4
- 3 granted · 1 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201420162018202020222024
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $1,000,000 | |
| Federal grant | National Science Foundation · Phase I · SBIR Phase I: Novel Stereo-enriched Libraries as Commercial Complex Building Blocks for Facile Development of Biologically Active Compounds on Large Scale | $224,996 | |
| Federal grant· 1 of 2 same day | National Science Foundation · Phase I · SBIR Phase I: AK-423: A broad-spectrum antiviral and immunomodulatory agent (COVID-19) | $256,000 | |
| Federal grant· 2 of 2 same day | National Science Foundation · Phase II · SBIR Phase II: Multiplex Expansion of the Chiral Carbon Catalog Platform towards Stereo-enriched Non-propionate Chemical Classes and Industrial Applications | $949,999 | |
| Federal grant | National Science Foundation · Phase II · SBIR Phase II: A Novel Host-Directed Broad-Spectrum Antiviral and Efficient Immunomodulatory Agent Against Coronaviruses: Lead Optimization Studies | $1,000,000 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1427 | Solutions BioMed LLC | — | $5.0M |
| 1428 | ALVEOLUS BIO, INC. | — | — |
| 1429 | IMAGINEERING TECHNOLOGIES INC | — | $14M |
| 1430 | Akanocure Pharmaceuticals, Inc. | — | $1.0M |
| 1431 | IT Bio, LLC | — | — |
| 1432 | Jericho Sciences, LLC | — | — |
| 1433 | Starwise Therapeutics LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Sherine AbdelmawlaDirector · Executive Officer
- Philip FuchsDirector · Executive Officer
- Mohammad NoshiDirector · Executive Officer
Patents
- Scalable Polypropionate Lactone Stereotetradsgranted
- Scalable Polypropionate Lactone Stereotetradsgranted
- Scalable Polypropionate Lactone Stereotetradsgranted
- Scalable Polypropionate Lactone Stereotetradsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.